These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma. Zhang JY; Zhu W; Imai H; Kiyosawa K; Chan EK; Tan EM Clin Exp Immunol; 2001 Jul; 125(1):3-9. PubMed ID: 11472419 [TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to IGF-II mRNA binding protein p62 and overexpression of p62 in human hepatocellular carcinoma. Zhang J; Chan EK Autoimmun Rev; 2002 May; 1(3):146-53. PubMed ID: 12849008 [TBL] [Abstract][Full Text] [Related]
4. Alpha-fetoprotein is an autoantigen in hepatocellular carcinoma and juvenile Batten disease. Bei R; Mizejewski GJ Front Biosci (Landmark Ed); 2020 Jan; 25(5):912-929. PubMed ID: 31585923 [TBL] [Abstract][Full Text] [Related]
5. The role of autoantigens in the driving of autoimmune diseases. Roitt IM Immunol Ser; 1993; 59():119-29. PubMed ID: 7681695 [No Abstract] [Full Text] [Related]
7. Letter: Impairment of rosette-forming T lymphocytes in cirrhosis and liver cancer. Williams AO; Samuel D; Daini AM N Engl J Med; 1975 Nov; 293(21):1100-1. PubMed ID: 170524 [No Abstract] [Full Text] [Related]
8. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Garnelo M; Tan A; Her Z; Yeong J; Lim CJ; Chen J; Lim KH; Weber A; Chow P; Chung A; Ooi LL; Toh HC; Heikenwalder M; Ng IO; Nardin A; Chen Q; Abastado JP; Chew V Gut; 2017 Feb; 66(2):342-351. PubMed ID: 26669617 [TBL] [Abstract][Full Text] [Related]
9. Immune repertoire: A potential biomarker and therapeutic for hepatocellular carcinoma. Han Y; Li H; Guan Y; Huang J Cancer Lett; 2016 Sep; 379(2):206-12. PubMed ID: 26188280 [TBL] [Abstract][Full Text] [Related]
12. Breakdown of self-tolerance and the pathogenesis of autoimmunity. Ring GH; Lakkis FG Semin Nephrol; 1999 Jan; 19(1):25-33. PubMed ID: 9952278 [TBL] [Abstract][Full Text] [Related]
13. Depressed cellular immunity in hepatocellular carcinoma patients. Lee CS; Chang KJ; Lin TY; Hsieh KH; Tung TC Taiwan Yi Xue Hui Za Zhi; 1981 Aug; 80(8):780-5. PubMed ID: 6273493 [No Abstract] [Full Text] [Related]
14. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes. Yang Y; Santamaria P J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740 [No Abstract] [Full Text] [Related]
15. Immunological status of patients of primary hepatic carcinoma. Khandelwal C; Khanna S Indian J Med Res; 1986 Jun; 83():591-3. PubMed ID: 3019883 [No Abstract] [Full Text] [Related]
16. [Co-transfection of staphylococcal enterotoxin A and B7.1 into human hepatocellular carcinoma cells and analysis of their immunological effect]. Li ZS; Sui YF; Ye J; Zhang XM Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):375. PubMed ID: 12837228 [No Abstract] [Full Text] [Related]
19. [A study on the hepatitis B virus associated nuclear antigen in a hepatocellular carcinoma cell line CZHC8571]. Chen ZP Zhonghua Yi Xue Za Zhi; 1988 Oct; 68(10):572-4, 40. PubMed ID: 2853989 [No Abstract] [Full Text] [Related]
20. Autoimmunity, autoinflammation and lymphoma in combined immunodeficiency (CID). Schuetz C; Niehues T; Friedrich W; Schwarz K Autoimmun Rev; 2010 May; 9(7):477-82. PubMed ID: 20146941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]